Great Lakes Advisors LLC Invests $10.16 Million in CVS Health Corporation $CVS

Great Lakes Advisors LLC purchased a new stake in shares of CVS Health Corporation (NYSE:CVS) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 98,261 shares of the pharmacy operator’s stock, valued at approximately $10,165,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Beaird Harris Wealth Management LLC increased its stake in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares in the last quarter. J.Safra Asset Management Corp bought a new stake in shares of CVS Health in the 2nd quarter worth approximately $30,000. Dunhill Financial LLC purchased a new stake in shares of CVS Health in the 2nd quarter worth approximately $32,000. Swiss RE Ltd. purchased a new stake in shares of CVS Health in the 4th quarter worth approximately $26,000. Finally, Sankala Group LLC bought a new position in CVS Health during the 4th quarter valued at approximately $28,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Wall Street Zen raised CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. UBS Group raised their price target on CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Argus lifted their price target on CVS Health from $90.00 to $104.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Wells Fargo & Company increased their price objective on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Finally, Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research note on Thursday, August 6th. Twenty-two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $106.75.

CVS Health Trading Up 0.9%

Shares of NYSE:CVS opened at $94.87 on Wednesday. The stock’s 50-day simple moving average is $102.41 and its two-hundred day simple moving average is $88.56. The stock has a market capitalization of $121.33 billion, a price-to-earnings ratio of 25.10, a PEG ratio of 0.93 and a beta of 0.61. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the prior year, the firm earned $1.81 EPS. The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS reported strong second-quarter results, with earnings per share rising more than 40% year over year as profitability in its Health Care Benefits segment improved. The company also raised its 2026 adjusted operating income outlook, reinforcing the recovery story. CVS Q2 EPS Gains From Improved Health Care Benefits Profitability
• Positive Sentiment: CVS appointed Teresa Heitsenrether, JPMorgan’s data and analytics chief, to its board. Her technology, analytics and operating experience could support CVS’s artificial-intelligence and data initiatives, potentially improving efficiency and decision-making across its businesses. CVS adds JPMorgan data executive to board amid AI push
• Positive Sentiment: Brokerages assigned CVS an average “Moderate Buy” rating, reflecting improved earnings momentum and optimism about Aetna’s performance. CVS Health Given Average Rating of Moderate Buy

Insider Buying and Selling at CVS Health

In other news, Director Larry Robbins sold 370,462 shares of CVS Health stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the transaction, the director owned 4,824,799 shares in the company, valued at $450,877,466.55. This trade represents a 7.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.85% of the stock is owned by corporate insiders.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.